Cisplatin-based chemotherapy: add high-frequency audiometry in the regimen (Record no. 31130)

000 -LEADER
fixed length control field 01866pab a2200337 454500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150901b2009 xxu||||| |||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency Tata Memorial Hospital
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title English
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number
Item number
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name R Arora
245 ## - TITLE STATEMENT
Title Cisplatin-based chemotherapy: add high-frequency audiometry in the regimen
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Date of publication, distribution, etc. 2009
300 ## - PHYSICAL DESCRIPTION
Extent 311-317
490 ## - SERIES STATEMENT
Series statement
Volume/sequential designation Vol 46 Issues 4
520 ## - SUMMARY, ETC.
Summary, etc. Background : Cisplatin-induced ototoxicity shows high interindividual variability and is often accompanied by transient or permanent tinnitus. It is not possible to identify the susceptible individuals before commencement of the treatment. We conducted a prospective, randomized and observational study in a tertiary care centre and evaluated the effects of different doses of cisplatin on hearing. Materials and Methods : Fifty-seven patients scheduled for cisplatin-based chemotherapy were included in the study. All patients were divided into three groups depending on the dose of cisplatin infused in 3 weeks. Results : The subjective hearing loss was found in seven patients, while six patients had tinnitus during the chemotherapy. The hearing loss was sensorineural, dose dependent, symmetrical, bilateral and irreversible. Higher frequencies were first to be affected in cisplatin chemotherapy. Conclusion : As use of high-frequency audiometry is still limited in research work only, we need a strict protocol of a
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element hearing loss,,,,
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element cisplatin
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Audiometry
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Seam RK
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Sharma DR
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Mohindroo NK
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Azad RK
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name anujagdeep@yahoo.co.in
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Thakur JS
773 ## - HOST ITEM ENTRY
Host Biblionumber 78063
Main entry heading Indian Journal of Cancer
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier \LibMM01ArticlesAR9641.pdf
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
a Oct-Dec
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN)
a India
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN)
a Original Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Permanent Location Current Location Date acquired Cost, normal purchase price Full call number Barcode Date last seen Price effective from Koha item type
        Tata Memorial Hospital Tata Memorial Hospital 2009-09-11 0.00 AR9641 2015-09-02 2015-09-02 Articles

Powered by Koha